Integrative analysis of transcriptome and genome indicates two potential genomic islands are associated with pathogenesis of Mycobacterium tuberculosis

Gene

Volumn 489, Issue 1, 2011, Pages 21-29

  Yu, Guohua ^a   Fu, Xuping ^a   Jin, Ke ^a   Zhang, Lu ^a   Wu, Wei ^a   Cui, Zhenling ^b   Hu, Zhongyi ^b   Li, Yao ^a  

^a FUDAN UNIVERSITY   (China)

^b TONGJI UNIVERSITY   (China)

Author keywords

Aerobic respiration; PE_PGRS; Persistence; Sulfolipid 1; Virulence

Indexed keywords

TRANSCRIPTOME;

ARTICLE; BREATHING; CONTROLLED STUDY; GENE; GENE CLUSTER; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOMIC ISLAND; HUMAN; MICROARRAY ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PERSISTENT VIRUS INFECTION; POLYMORPHIC LOCUS; PRIORITY JOURNAL; RV3508 GENE; SEQUENCE ANALYSIS; SURVIVAL; TUBERCULOSIS; VIRULENCE;

BASE SEQUENCE; DOWN-REGULATION; GENE EXPRESSION PROFILING; GENOMIC ISLANDS; LIPIDS; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM TUBERCULOSIS; NITROIMIDAZOLES;

MYCOBACTERIUM TUBERCULOSIS;

EID: 80053958688     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2011.08.019     Document Type: Article

References (99)

1. Abdallah A.M., et al. Type VII secretion-mycobacteria show the way. Nat. Rev. Microbiol. 2007, 5:883-891.
2. Abdallah A.M., et al. PPE and PE_PGRS proteins of Mycobacterium marinum are transported via the type VII secretion system ESX-5. Mol. Microbiol. 2009, 73:329-340.
3. Bansal K., et al. PE_PGRS antigens of Mycobacterium tuberculosis induce maturation and activation of human dendritic cells. J. Immunol. 2010, 184:3495-3504.
4. Becq J., et al. Contribution of horizontally acquired genomic islands to the evolution of the tubercle bacilli. Mol. Biol. Evol. 2007, 24:1861-1871.
5. Bhatt K., Gurcha S.S., Bhatt A., Besra G.S., Jacobs W.J. Two polyketide-synthase-associated acyltransferases are required for sulfolipid biosynthesis in Mycobacterium tuberculosis. Microbiology 2007, 153:513-520.
6. Boshoff H.I., Myers T.G., Copp B.R., McNeil M.R., Wilson M.A., Barry C.R. The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism: novel insights into drug mechanisms of action. J. Biol. Chem. 2004, 279:40174-40184.
7. Boyd E.F., Almagro-Moreno S., Parent M.A. Genomic islands are dynamic, ancient integrative elements in bacterial evolution. Trends Microbiol. 2009, 17:47-53.
8. Brennan M.J., Delogu G. The PE multigene family: a 'molecular mantra' for mycobacteria. Trends Microbiol. 2002, 10:246-249.
9. Brennan M.J., et al. Evidence that mycobacterial PE_PGRS proteins are cell surface constituents that influence interactions with other cells. Infect. Immun. 2001, 69:7326-7333.
10. Brent M.R. Genome annotation past, present, and future: how to define an ORF at each locus. Genome Res. 2005, 15:1777-1786.
11. Brozna J.P., Horan M., Rademacher J.M., Pabst K.M., Pabst M.J. Monocyte responses to sulfatide from Mycobacterium tuberculosis: inhibition of priming for enhanced release of superoxide, associated with increased secretion of interleukin-1 and tumor necrosis factor alpha, and altered protein phosphorylation. Infect. Immun. 1991, 59:2542-2548.
12. Carcy B., Precigout E., Schetters T., Gorenflot A. Genetic basis for GPI-anchor merozoite surface antigen polymorphism of Babesia and resulting antigenic diversity. Vet. Parasitol. 2006, 138:33-49.
13. Chaitra M.G., Shaila M.S., Nayak R. Evaluation of T-cell responses to peptides with MHC class I-binding motifs derived from PE_PGRS 33 protein of Mycobacterium tuberculosis. J. Med. Microbiol. 2007, 56:466-474.
14. Chaitra M.G., Shaila M.S., Nayak R. Characterization of T-cell immunogenicity of two PE/PPE proteins of Mycobacterium tuberculosis. J. Med. Microbiol. 2008, 57:1079-1086.
15. Chan J., Xing Y., Magliozzo R.S., Bloom B.R. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J. Exp. Med. 1992, 175:1111-1122.
16. Chesne-Seck M.L., et al. A point mutation in the two-component regulator PhoP-PhoR accounts for the absence of polyketide-derived acyltrehaloses but not that of phthiocerol dimycocerosates in Mycobacterium tuberculosis H37Ra. J. Bacteriol. 2008, 190:1329-1334.
17. Cole S.T., et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 1998, 393:537-544.
18. Converse S.E., Mougous J.D., Leavell M.D., Leary J.A., Bertozzi C.R., Cox J.S. MmpL8 is required for sulfolipid-1 biosynthesis and Mycobacterium tuberculosis virulence. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:6121-6126.
19. Cubillos-Ruiz A., Morales J., Zambrano M.M. Analysis of the genetic variation in Mycobacterium tuberculosis strains by multiple genome alignments. BMC Res. Notes 2008, 1:110.
20. de Souza G.A., Softeland T., Koehler C.J., Thiede B., Wiker H.G. Validating divergent ORF annotation of the Mycobacterium leprae genome through a full translation data set and peptide identification by tandem mass spectrometry. Proteomics 2009, 9:3233-3243.
21. Deb C., et al. A novel in vitro multiple-stress dormancy model for Mycobacterium tuberculosis generates a lipid-loaded, drug-tolerant, dormant pathogen. PLoS One 2009, 4:e6077.
22. Delogu G., Brennan M.J. Comparative immune response to PE and PE_PGRS antigens of Mycobacterium tuberculosis. Infect. Immun. 2001, 69:5606-5611.
23. Delogu G., et al. PE_PGRS proteins are differentially expressed by Mycobacterium tuberculosis in host tissues. Microbes Infect. 2006, 8:2061-2067.
24. Dheenadhayalan V., Delogu G., Brennan M.J. Expression of the PE_PGRS 33 protein in Mycobacterium smegmatis triggers necrosis in macrophages and enhanced mycobacterial survival. Microbes Infect. 2006, 8:262-272.
25. Domenech P., Reed M.B., Dowd C.S., Manca C., Kaplan G., Barry C.R. The role of MmpL8 in sulfatide biogenesis and virulence of Mycobacterium tuberculosis. J. Biol. Chem. 2004, 279:21257-21265.
26. Dutta N.K., Mehra S., Kaushal D. A Mycobacterium tuberculosis sigma factor network responds to cell-envelope damage by the promising anti-mycobacterial thioridazine. PLoS One 2010, 5:e10069.
27. Edgar R.C. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 2004, 32:1792-1797.
28. Espitia C., et al. The PE-PGRS glycine-rich proteins of Mycobacterium tuberculosis: a new family of fibronectin-binding proteins?. Microbiology 1999, 145(Pt 12):3487-3495.
29. Fontan P., Aris V., Ghanny S., Soteropoulos P., Smith I. Global transcriptional profile of Mycobacterium tuberculosis during THP-1 human macrophage infection. Infect. Immun. 2008, 76:717-725.
30. Friedman C.R., et al. Widespread dissemination of a drug-susceptible strain of Mycobacterium tuberculosis. J. Infect. Dis. 1997, 176:478-484.
31. Gangadharam P.R., Cohn M.L., Middlebrook G. Infectivity, pathogenicity and sulpholipid fraction of some indian and british strains of tubercle bacilli. Tubercle 1963, 44:452-455.
32. Gao F., Zhang C.T. GC-Profile: a web-based tool for visualizing and analyzing the variation of GC content in genomic sequences. Nucleic Acids Res. 2006, 34:W686-W691.
33. Gao Q., Kripke K., Arinc Z., Voskuil M., Small P. Comparative expression studies of a complex phenotype: cord formation in Mycobacterium tuberculosis. Tuberculosis (Edinb.) 2004, 84:188-196.
34. Gao Q., Kripke K.E., Saldanha A.J., Yan W., Holmes S., Small P.M. Gene expression diversity among Mycobacterium tuberculosis clinical isolates. Microbiology 2005, 151:5-14.
35. Garcia-Vallve S., Guzman E., Montero M.A., Romeu A. HGT-DB: a database of putative horizontally transferred genes in prokaryotic complete genomes. Nucleic Acids Res. 2003, 31:187-189.
36. Gey V.P.N., Sampson S.L., Lee H., Kim Y., van Helden P.D., Warren R.M. Evolution and expansion of the Mycobacterium tuberculosis PE and PPE multigene families and their association with the duplication of the ESAT-6 (esx) gene cluster regions. BMC Evol. Biol. 2006, 6:95.
37. Gilleron M., et al. Diacylated sulfoglycolipids are novel mycobacterial antigens stimulating CD1-restricted T cells during infection with Mycobacterium tuberculosis. J. Exp. Med. 2004, 199:649-659.
38. Ginsberg A.M., Laurenzi M.W., Rouse D.J., Whitney K.D., Spigelman M.K. Safety, tolerability, and pharmacokinetics of PA-824 in healthy subjects. Antimicrob. Agents Chemother. 2009, 53:3720-3725.
39. Gonzalo A.J., et al. The virulence-associated two-component PhoP-PhoR system controls the biosynthesis of polyketide-derived lipids in Mycobacterium tuberculosis. J. Biol. Chem. 2006, 281:1313-1316.
40. Goren M.B., Brokl O., Schaefer W.B. Lipids of putative relevance to virulence in Mycobacterium tuberculosis: correlation of virulence with elaboration of sulfatides and strongly acidic lipids. Infect. Immun. 1974, 9:142-149.
41. Goren M.B., D'Arcy H.P., Young M.R., Armstrong J.A. Prevention of phagosome-lysosome fusion in cultured macrophages by sulfatides of Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. U.S.A. 1976, 73:2510-2514.
42. Graham J.E., Clark-Curtiss J.E. Identification of Mycobacterium tuberculosis RNAs synthesized in response to phagocytosis by human macrophages by selective capture of transcribed sequences (SCOTS). Proc. Natl. Acad. Sci. U.S.A. 1999, 96:11554-11559.
43. Guy L. Identification and characterization of pathogenicity and other genomic islands using base composition analyses. Future Microbiol. 2006, 1:309-316.
44. Hampshire T., et al. Stationary phase gene expression of Mycobacterium tuberculosis following a progressive nutrient depletion: a model for persistent organisms?. Tuberculosis (Edinb.) 2004, 84:228-238.
45. Ho S.S., Fedynak A., Hsiao W.W., Langille M.G., Brinkman F.S. The association of virulence factors with genomic islands. PLoS One 2009, 4:e8094.
46. Hsiao W., Wan I., Jones S.J., Brinkman F.S. IslandPath: aiding detection of genomic islands in prokaryotes. Bioinformatics 2003, 19:418-420.
47. Jang J., Becq J., Gicquel B., Deschavanne P., Neyrolles O. Horizontally acquired genomic islands in the tubercle bacilli. Trends Microbiol. 2008, 16:303-308.
48. Juhas M., van der Meer J.R., Gaillard M., Harding R.M., Hood D.W., Crook D.W. Genomic islands: tools of bacterial horizontal gene transfer and evolution. FEMS Microbiol. Rev. 2009, 33:376-393.
49. Karlin S. Detecting anomalous gene clusters and pathogenicity islands in diverse bacterial genomes. Trends Microbiol. 2001, 9:335-343.
50. Kawashima Y., et al. Adaptation of HIV-1 to human leukocyte antigen class I. Nature 2009, 458:641-645.
51. Koh K.W., Soh S.E., Seah G.T. Strong antibody responses to Mycobacterium tuberculosis PE-PGRS62 protein are associated with latent and active tuberculosis. Infect. Immun. 2009, 77:3337-3343.
52. Kumar P., et al. PapA1 and PapA2 are acyltransferases essential for the biosynthesis of the Mycobacterium tuberculosis virulence factor sulfolipid-1. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:11221-11226.
53. Langille M.G., Brinkman F.S. IslandViewer: an integrated interface for computational identification and visualization of genomic islands. Bioinformatics 2009, 25:664-665.
54. Langille M.G., Hsiao W.W., Brinkman F.S. Evaluation of genomic island predictors using a comparative genomics approach. BMC Bioinformatics 2008, 9:329.
55. Langille M.G., Hsiao W.W., Brinkman F.S. Detecting genomic islands using bioinformatics approaches. Nat. Rev. Microbiol. 2010, 8:373-382.
56. Lee J.S., et al. Mutation in the transcriptional regulator PhoP contributes to avirulence of Mycobacterium tuberculosis H37Ra strain. Cell Host Microbe 2008, 3:97-103.
57. Lenaerts A.J., et al. Preclinical testing of the nitroimidazopyran PA-824 for activity against Mycobacterium tuberculosis in a series of in vitro and in vivo models. Antimicrob. Agents Chemother. 2005, 49:2294-2301.
58. Li A.H., Lam W.L., Stokes R.W. Characterization of genes differentially expressed within macrophages by virulent and attenuated Mycobacterium tuberculosis identifies candidate genes involved in intracellular growth. Microbiology 2008, 154:2291-2303.
59. Li A.H., et al. Contrasting transcriptional responses of a virulent and an attenuated strain of Mycobacterium tuberculosis infecting macrophages. PLoS One 2010, 5:e11066.
60. Mantri Y., Williams K.P. Islander: a database of integrative islands in prokaryotic genomes, the associated integrases and their DNA site specificities. Nucleic Acids Res. 2004, 32:D55-D58.
61. Mawuenyega K.G., et al. Mycobacterium tuberculosis functional network analysis by global subcellular protein profiling. Mol. Biol. Cell 2005, 16:396-404.
62. Middlebrook G., Coleman C.M., Schaefer W.B. Sulfolipid from virulent tubercle bacilli. Proc. Natl. Acad. Sci. U.S.A. 1959, 45:1801-1804.
63. Morris R.P., et al. Ancestral antibiotic resistance in Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:12200-12205.
64. Mostowy S., Cleto C., Sherman D.R., Behr M.A. The Mycobacterium tuberculosis complex transcriptome of attenuation. Tuberculosis (Edinb.) 2004, 84:197-204.
65. Niederweis M., Danilchanka O., Huff J., Hoffmann C., Engelhardt H. Mycobacterial outer membranes: in search of proteins. Trends Microbiol. 2010, 18:109-116.
66. Okamoto Y., Fujita Y., Naka T., Hirai M., Tomiyasu I., Yano I. Mycobacterial sulfolipid shows a virulence by inhibiting cord factor induced granuloma formation and TNF-alpha release. Microb. Pathog. 2006, 40:245-253.
67. Ou H.Y., et al. MobilomeFINDER: web-based tools for in silico and experimental discovery of bacterial genomic islands. Nucleic Acids Res. 2007, 35:W97-W104.
68. Pabst M.J., Gross J.M., Brozna J.P., Goren M.B. Inhibition of macrophage priming by sulfatide from Mycobacterium tuberculosis. J. Immunol. 1988, 140:634-640.
69. Pang X., et al. Evidence for complex interactions of stress-associated regulons in an mprAB deletion mutant of Mycobacterium tuberculosis. Microbiology 2007, 153:1229-1242.
70. Park H.D., et al. Rv3133c/dosR is a transcription factor that mediates the hypoxic response of Mycobacterium tuberculosis. Mol. Microbiol. 2003, 48:833-843.
71. Rachman H., et al. Unique transcriptome signature of Mycobacterium tuberculosis in pulmonary tuberculosis. Infect. Immun. 2006, 74:1233-1242.
72. Rajan I., Aravamuthan S., Mande S.S. Identification of compositionally distinct regions in genomes using the centroid method. Bioinformatics 2007, 23:2672-2677.
73. Ramakrishnan L., Federspiel N.A., Falkow S. Granuloma-specific expression of Mycobacterium virulence proteins from the glycine-rich PE-PGRS family. Science 2000, 288:1436-1439.
74. Rehren G., Walters S., Fontan P., Smith I., Zarraga A.M. Differential gene expression between Mycobacterium bovis and Mycobacterium tuberculosis. Tuberculosis (Edinb.) 2007, 87:347-359.
75. Rice P., Longden I., Bleasby A. EMBOSS: the European Molecular Biology Open Software Suite. Trends Genet. 2000, 16:276-277.
76. Rosas-Magallanes V., Deschavanne P., Quintana-Murci L., Brosch R., Gicquel B., Neyrolles O. Horizontal transfer of a virulence operon to the ancestor of Mycobacterium tuberculosis. Mol. Biol. Evol. 2006, 23:1129-1135.
77. Rousseau C., et al. Sulfolipid deficiency does not affect the virulence of Mycobacterium tuberculosis H37Rv in mice and guinea pigs. Infect. Immun. 2003, 71:4684-4690.
78. Singh P.P., Parra M., Cadieux N., Brennan M.J. A comparative study of host response to three Mycobacterium tuberculosis PE_PGRS proteins. Microbiology 2008, 154:3469-3479.
79. Singh R., et al. PA-824 kills nonreplicating Mycobacterium tuberculosis by intracellular NO release. Science 2008, 322:1392-1395.
80. Sirakova T.D., Thirumala A.K., Dubey V.S., Sprecher H., Kolattukudy P.E. The Mycobacterium tuberculosis pks2 gene encodes the synthase for the hepta- and octamethyl-branched fatty acids required for sulfolipid synthesis. J. Biol. Chem. 2001, 276:16833-16839.
81. Stewart G.R., Robertson B.D., Young D.B. Tuberculosis: a problem with persistence. Nat. Rev. Microbiol. 2003, 1:97-105.
82. Stover C.K., et al. A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis. Nature 2000, 405:962-966.
83. Tu Q., Ding D. Detecting pathogenicity islands and anomalous gene clusters by iterative discriminant analysis. FEMS Microbiol. Lett. 2003, 221:269-275.
84. van Passel M.W., Luyf A.C., van Kampen A.H., Bart A., van der Ende A. Deltarho-web, an online tool to assess composition similarity of individual nucleic acid sequences. Bioinformatics 2005, 21:3053-3055.
85. Vernikos G.S., Parkhill J. Interpolated variable order motifs for identification of horizontally acquired DNA: revisiting the Salmonella pathogenicity islands. Bioinformatics 2006, 22:2196-2203.
86. Voskuil M.I., et al. Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program. J. Exp. Med. 2003, 198:705-713.
87. Voskuil M.I., Visconti K.C., Schoolnik G.K. Mycobacterium tuberculosis gene expression during adaptation to stationary phase and low-oxygen dormancy. Tuberculosis (Edinb.) 2004, 84:218-227.
88. Waack S., et al. Score-based prediction of genomic islands in prokaryotic genomes using hidden Markov models. BMC Bioinformatics 2006, 7:142.
89. Waddell S.J., Stabler R.A., Laing K., Kremer L., Reynolds R.C., Besra G.S. The use of microarray analysis to determine the gene expression profiles of Mycobacterium tuberculosis in response to anti-bacterial compounds. Tuberculosis (Edinb.) 2004, 84:263-274.
90. Walters S.B., Dubnau E., Kolesnikova I., Laval F., Daffe M., Smith I. The Mycobacterium tuberculosis PhoPR two-component system regulates genes essential for virulence and complex lipid biosynthesis. Mol. Microbiol. 2006, 60:312-330.
91. Wayne L.G., Hayes L.G. An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence. Infect. Immun. 1996, 64:2062-2069.
92. Yang Z. PAML 4: phylogenetic analysis by maximum likelihood. Mol. Biol. Evol. 2007, 24:1586-1591.
93. Zahrt T.C., Deretic V. Mycobacterium tuberculosis signal transduction system required for persistent infections. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:12706-12711.
94. Zhang C.T., Zhang R. Genomic islands in Rhodopseudomonas palustris. Nat. Biotechnol. 2004, 22:1078-1079.
95. Zhang L., English D., Andersen B.R. Activation of human neutrophils by Mycobacterium tuberculosis-derived sulfolipid-1. J. Immunol. 1991, 146:2730-2736.
96. Zhang L., Goren M.B., Holzer T.J., Andersen B.R. Effect of Mycobacterium tuberculosis-derived sulfolipid I on human phagocytic cells. Infect. Immun. 1988, 56:2876-2883.
97. Zhang R., Zhang C.T. A systematic method to identify genomic islands and its applications in analyzing the genomes of Corynebacterium glutamicum and Vibrio vulnificus CMCP6 chromosome I. Bioinformatics 2004, 20:612-622.
98. Zhang R., Zhang C.T. Genomic islands in the Corynebacterium efficiens genome. Appl. Environ. Microbiol. 2005, 71:3126-3130.
99. Zheng H., et al. Genetic basis of virulence attenuation revealed by comparative genomic analysis of Mycobacterium tuberculosis strain H37Ra versus H37Rv. PLoS One 2008, 3:e2375.